Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
Premium Content
Most Read Stories
UPDATE: Nokia Corp (NOK) Pops as Huawei May Consider Buying the Company
Next Big Thing from Apple (AAPL) Could be a Big Flop - Analyst
BlackBerry (BBRY) Ests Boosted on Strong Channel Fill; Short Rally Possible, RBC Says
Send to a Friend
Font Size:
Increase
Decrease
VRX and MRK Related Headlines
Go Back
Jul 3, 2012 01:18PM
UBS Q2 Preview on U.S. Pharmaceuticals: Safe Havens in Generic, Specialty and Large-Cap
VRX and MRK Related Press Releases
Go Back
VRX and MRK Related SEC Filings
Go Back
